Polydex Pharmaceuticals Ltd &lt;POLYXF>said the Canadian unit of American Home Products Corp's AyerstLabs subsidiary will probably receive marketing anddistribution rights to its cholesterol lowering drug Dexide,now in clinical trials in Canada.    George Usher, president of Dextran Products Limited, theCanadian subsidiary of Polydex, said that the company will filein August to both U.S. and Canadian regulatory authorities toreceive marketing approval for the drug. He also said thatAmerican Home Products would quite possibly get distributionrights to the drug in the U.S.    Reuter&#3;